We report a case of reactivated biopsy-proven cytomegalovirus proctitis complicating the course of severe COVID-19 pneumonia treated with dexamethasone, anakinra and lopinavir/ritonavir. No other contributing factor was found than iatrogenic immunosuppression and COVID-19 immune dysregulation. We draw attention to the immunosuppressive risk when treating severe COVID-19 pneumonia with immunomodulators.
All Keywords
【저자키워드】 COVID-19, Dexamethasone, Anakinra, Cytomegalovirus infections, Rectal diseases, Proctitis, 【초록키워드】 Severe COVID-19 pneumonia, Immunosuppression, risk, immunomodulators, immunosuppressive, immune dysregulation, Course, treated, iatrogenic, 【제목키워드】 cytomegalovirus, Immunosuppressive treatment, complication of COVID-19,
【저자키워드】 COVID-19, Dexamethasone, Anakinra, Cytomegalovirus infections, Rectal diseases, Proctitis, 【초록키워드】 Severe COVID-19 pneumonia, Immunosuppression, risk, immunomodulators, immunosuppressive, immune dysregulation, Course, treated, iatrogenic, 【제목키워드】 cytomegalovirus, Immunosuppressive treatment, complication of COVID-19,